COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results and Recent Corporate Developments

01/03/2018 - 22:01

-- Fourth quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $57.3 million -- -- Cash and investment balance of $1.1 billion as of December 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- [...]

Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer

01/03/2018 - 22:01

WATERTOWN, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results

01/03/2018 - 22:01

HOLLISTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs

01/03/2018 - 22:01

AMES, Iowa, March 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the fourth quarter and year ended 2017, as well as progress in its clinical [...]

Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 22:01

BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat [...]

MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension

01/03/2018 - 22:01

WESTLAKE VILLAGE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Nkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of Growth

01/03/2018 - 20:05

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing natural killer (NK) immune cells to fight cancer, announced that it has named [...]

UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

01/03/2018 - 19:45

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]

Evolent Health CEO Frank Williams Joins Syapse Board of Directors

01/03/2018 - 19:43

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Syapse, a leading precision medicine company, announced today that Frank Williams, the co-founder and CEO of Evolent Health, has joined the company’s board of directors [...]

Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018

01/03/2018 - 18:11

ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2018 at 19.10 EET Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 [...]

CROSSJECT : Financial calendar 2018

01/03/2018 - 18:00

Press release Crossject announces its financial calendar 2018 Dijon, 1st March 2018 CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ), a specialty pharma company developing a portfolio of innovative combined drugs for use in [...]

CROSSJECT : Agenda financier 2018

01/03/2018 - 18:00

Communiqué de Presse Crossject annonce son agenda financier 2018 Dijon, le 28 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés [...]

Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2017 Financial Results

01/03/2018 - 18:00

NEWTOWN, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a [...]

Clover Health Adds Airbnb, Amazon and Google Alums to Executive Team

01/03/2018 - 18:00

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Clover Health , a health insurance company using data and technology to fill gaps in care and improve health outcomes, today announced the addition of three new [...]

SuperSonic Imagine Delivers 2,000th Aixplorer® to the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China

01/03/2018 - 18:00

AIX-EN-PROVENCE, France, March 01, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specialised in medical imaging using ultrasound, announces the installation of its 2,000 th [...]

OpGen to Present at the Cowen and Company 38th Annual Health Care Conference

01/03/2018 - 17:50

GAITHERSBURG, Md., March 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that Evan Jones, Chairman and Chief Executive Officer of the Company, will present a corporate overview at the Cowen and [...]

Sanofi : Disclosure of trading in own shares

01/03/2018 - 17:46

Attachment: http://www.globenewswire.com/NewsRoom/AttachmentNg/a36fde5a-6fc4-44c6-ac97-c88aa581889e

Sanofi : Déclaration des transactions sur actions propres

01/03/2018 - 17:46

Attachment: http://www.globenewswire.com/NewsRoom/AttachmentNg/9184f946-a2fd-4cde-9873-ed84491238e9

NICOX : Nombre total de droits de vote au 28 février 2018

01/03/2018 - 17:46

Nicox SA Société anonyme au capital de 29 506 038 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er mars 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]